The Department of Labor has finalized its PBM fee disclosure rule, introducing new requirements aimed at giving large self-funded health plans a clearer picture of how their PBMs are compensated.
In this episode of On Point with Navion, Lad Williamson sits down with Jason Peterson, RPh, Navion’s Director of Clinical Strategy, to break down what the final rule requires, who it applies to and how employers, TPAs and brokers can prepare for the changes ahead.
Breaking Down the Final PBM Fee Disclosure Rule
The final PBM fee disclosure rule builds on existing ERISA requirements for employers to evaluate whether their PBM arrangements and compensation are reasonable.
It generally applies to large self-funded ERISA health plans, including qualifying level-funded arrangements and Taft-Hartley multiemployer plans. Fully insured and governmental plans fall outside of the rule’s specific requirements.
Importantly, coverage depends on the services an organization performs or arranges, regardless of whether it identifies as a PBM. For example, a TPA that contracts directly with a plan to arrange pharmacy benefits through a subcontracted PBM may also be responsible for the required disclosures.
The rule establishes three key transparency requirements:
- Initial disclosures: Covered service providers must disclose their services and expected direct and indirect compensation prior to contracting. For renewals and extensions, providing disclosures at least 90 days in advance is considered reasonable.
- Ongoing reporting: Actual and expected compensation must be reported semiannually, or quarterly upon request.
- Annual audit rights: Plans must be able to independently audit the accuracy of required disclosures at least once a year.
These disclosures provide greater visibility into manufacturer rebates, administrative fees, spread pricing, pharmacy clawbacks and payments involving PBM affiliates, agents and subcontractors.
The rule takes effect January 4, 2027 and applies to plan years beginning on or after July 1, 2027. For calendar-year plans, the requirements apply beginning January 1, 2028.
How Employers, TPAs and Brokers Should Prepare
The new requirements will give plan sponsors greater visibility into PBM compensation and potential conflicts of interest. Preparing to evaluate that information will be an important part of effective contract oversight.
Key steps for each group include:
- Employers and plan sponsors: Review existing PBM contracts, compensation arrangements, reporting provisions and audit rights. Identify potentially covered service providers beyond the traditional PBM, including medical-benefit drug vendors.
- TPAs: Examine client contracts and services performed or arranged to determine whether disclosure obligations apply. Evaluate medical drug rebates, specialty management programs, indirect compensation, subcontractor relationships and existing reporting capabilities.
- Brokers and consultants: Help clients identify covered providers, understand what information they’re entitled to receive and determine whether contracts need revisions to support disclosure and audit requirements. Begin conversations with PBMs and TPAs ahead of implementation.
Need help evaluating your PBM arrangements? Navion works with employers, brokers and TPAs to review PBM contracts, analyze pharmacy costs and verify financial performance. Let’s talk!